[{"address1": "42 Hayarkon Street", "city": "Yavne", "zip": "8122745", "country": "Israel", "phone": "972 7 797 14100", "fax": "972 7 797 14111", "website": "https://www.mediwound.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; and MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.", "fullTimeEmployees": 100, "companyOfficers": [{"maxAge": 1, "name": "Mr. Ofer  Gonen B.Sc.", "age": 51, "title": "Chief Executive Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 649000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Hani  Luxenburg", "age": 51, "title": "Chief Financial Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 235000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yaron  Meyer Adv.", "age": 45, "title": "Executive VP, General Counsel & Corporate Secretary", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 299000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ety  Klinger MBA, Ph.D.", "age": 62, "title": "Chief Research & Development Officer", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 377000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lior  Rosenberg M.D.", "age": 78, "title": "Co-Founder", "yearBorn": 1946, "fiscalYear": 2023, "totalPay": 727000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shmulik  Hess Ph.D.", "age": 51, "title": "COO & Chief Commercial Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Liron  Gal", "title": "Executive Director of Manufacturing Science & Technology", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Barry J. Wolfenson", "age": 57, "title": "Executive Vice President of Strategy & Corporate Development", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert J. Snyder CWS, D.P.M., F.A.C.F.A.S., FFPM, M.B.A., M.Sc.", "age": 74, "title": "Chief Medical Officer", "yearBorn": 1950, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 18.62, "open": 18.68, "dayLow": 18.31, "dayHigh": 19.2, "regularMarketPreviousClose": 18.62, "regularMarketOpen": 18.68, "regularMarketDayLow": 18.31, "regularMarketDayHigh": 19.2, "beta": 0.81, "forwardPE": -8.109522, "volume": 47993, "regularMarketVolume": 47993, "averageVolume": 65628, "averageVolume10days": 66630, "averageDailyVolume10Day": 66630, "bid": 18.67, "ask": 18.93, "bidSize": 100, "askSize": 100, "marketCap": 202420400, "fiftyTwoWeekLow": 12.78, "fiftyTwoWeekHigh": 24.0, "priceToSalesTrailing12Months": 10.264727, "fiftyDayAverage": 18.1138, "twoHundredDayAverage": 17.649876, "currency": "USD", "enterpriseValue": 158089760, "profitMargins": -1.42287, "floatShares": 7274232, "sharesOutstanding": 10790000, "sharesShort": 820432, "sharesShortPriorMonth": 758788, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.076, "heldPercentInsiders": 0.19754, "heldPercentInstitutions": 0.46492, "shortRatio": 10.92, "shortPercentOfFloat": 0.0889, "impliedSharesOutstanding": 11153000, "bookValue": 3.257, "priceToBook": 5.759902, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -28059000, "trailingEps": -2.91, "forwardEps": -2.22, "lastSplitFactor": "1:7", "lastSplitDate": 1671494400, "enterpriseToRevenue": 8.017, "enterpriseToEbitda": -9.56, "52WeekChange": 0.41920733, "SandP52WeekChange": 0.22903383, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "MDWD", "underlyingSymbol": "MDWD", "shortName": "MediWound Ltd.", "longName": "MediWound Ltd.", "firstTradeDateEpochUtc": 1395322200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "1d731941-74dc-3c53-8065-5808c744e4bc", "messageBoardId": "finmb_1570881", "gmtOffSetMilliseconds": -18000000, "currentPrice": 18.76, "targetHighPrice": 36.0, "targetLowPrice": 25.0, "targetMeanPrice": 29.0, "targetMedianPrice": 27.5, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 45562000, "totalCashPerShare": 4.335, "ebitda": -16537000, "totalDebt": 6460000, "quickRatio": 1.989, "currentRatio": 2.107, "totalRevenue": 19720000, "debtToEquity": 18.87, "revenuePerShare": 2.062, "returnOnAssets": -0.15347, "returnOnEquity": -0.83403, "grossProfits": 2450000, "freeCashflow": -8842375, "operatingCashflow": -14602000, "revenueGrowth": -0.088, "grossMargins": 0.124239996, "ebitdaMargins": -0.83859, "operatingMargins": -1.1667, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]